Here are the S-3 shelf registrations from PAVmed Inc. (PAVM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow PAVM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAVM filings page.
PAVmed Inc. files a registration statement to permit resale of 9,230,786 shares of common stock by selling stockholders. The shares consist of 4,615,393 shares issued upon conversion of Series D preferred stock and 4,615,393 shares issuable upon exercise of warrants tied to that private placement. The company is not selling shares here and will receive proceeds only if the warrants are exercised — up to $30,000,000 — with proceeds intended for working capital and general corporate purposes. The prospectus discloses the Series D conversion price of $6.50 per share, a warrant exercise mechanism that may deliver common shares in lieu of preferred, and a callable feature tied to MolDx publication of a draft Medicare local coverage determination.